| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
HealthEquity (NASDAQ:HQY) reported its Q4 earnings results on Tuesday, March 19, 2024 at 04:01 PM.
Here's what investors need to know about the announcement.
HealthEquity beat estimated earnings by 12.0%, reporting an EPS of $0.63 versus an estimate of $0.56.
Revenue was up $28.55 million from the same period last year.
Last quarter the company beat on EPS by $0.1 which was followed by a 0.0% increase in the share price the next day.
Here's a look at HealthEquity's past performance:
| Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| EPS Estimate | 0.5 | 0.47 | 0.41 | 0.35 |
| EPS Actual | 0.6 | 0.53 | 0.50 | 0.37 |
| Revenue Estimate | 243.61M | 238.89M | 239.43M | 230.72M |
| Revenue Actual | 249.22M | 243.55M | 244.43M | 233.84M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
HealthEquity management provided guidance for FY 2024, expecting earnings between $2.2 and $2.24 per share.
To track all earnings releases for HealthEquity visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: HQY
